Dasatinib

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on February 8, 2020.

Return to the list of Patented Medicine Litigation page.





Dasatinib

SPRYCEL – Bristol-Myers Squibb Canada Co. (NOC Search)

Patents:

  • 2366932: APOTEX
  • 2519898: TARO PHARMACEUTICALS, APOTEX, TEVA, PHARMASCIENCE
  • 2555291: PHARMASCIENCE, TARO PHARMACEUTICALS, TEVA

APOTEX

PHARMASCIENCE

TARO PHARMACEUTICALS

TEVA


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property